Improving the quality of life

Agendia’s mission is to improve the quality of life for cancer patients by providing healthcare professionals and pharmaceutical companies with state-of-the-art services that enable safe and effective personalized medicine.

Clinically relevant expression profiling

As an innovative molecular cancer diagnostics company, Agendia uses its knowledge and expertise in the application of clinically useful gene expression profiling to facilitate diagnosis, prognosis and cancer therapeutics development.

Knowledge of a tumor's gene expression profile can, for example, be used to predict the ability of an individual tumor to spread, to predict a tumor’s response to anti-cancer drugs or to identify the site of origin in cases where the location of the primary tumor is unknown. In these examples, the information obtained is crucial to enable physicians to determine the best course of treatment for an individual patient and for drug developers to differentiate between responders and non-responders when setting up clinical trials.

Agendia aims to develop a wide range of high-quality diagnostic methods using gene expression profiling based on microarray technologies to determine clinically relevant properties of tumors.